Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2003
01/08/2003EP1272273A1 A device for analytical determinations
01/08/2003EP1272217A1 Use of inhibition of a gas6 function or of a gas6 receptor for preventing and treating a cardiovascular disease
01/08/2003EP1272205A1 Sialoadhesin factor-2 antibodies
01/08/2003EP1272178A2 Bilirubin or biliverdin degradation fragments
01/08/2003EP1200813A4 Method and apparatus for determining diffusible hydrogen concentrations
01/08/2003EP1056490A4 Cell separation device and metering syringe
01/08/2003EP0996727B1 Gene conferring obese phenotype
01/08/2003EP0963192B1 Diaminobenzoic acid derivatives as dye precursors
01/08/2003EP0934526B1 Methods and means for selecting peptides and proteins having specific affinity for a target
01/08/2003EP0929579B1 Monoclonal antibodies against a human act and serine protease complex
01/08/2003EP0793685B1 The hydrophilization of hydrophobic polymers
01/08/2003EP0751996B1 Luciferases
01/08/2003EP0684472B1 Immunoassay method and apparatus therefor
01/08/2003CN2530268Y Disposable urine collecting centrifugal cup
01/08/2003CN2530267Y Electromagnetic cell uniform mixer
01/08/2003CN2530263Y Optical fibre sensor for detecting bioluminescence
01/08/2003CN2530257Y 液体分配阀 The liquid dispensing valve
01/08/2003CN1390304A Early cancer tumor marker
01/08/2003CN1390302A Dual riser/single capillary viscometer
01/08/2003CN1390264A Long oligonucleotide arrays
01/08/2003CN1390263A High throughput assay system
01/08/2003CN1390261A GMP synthetase derived from plants
01/08/2003CN1390253A High order nucleic acid based structures
01/08/2003CN1390233A Antitumor antibodies, proteins, and uses thereof
01/08/2003CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use
01/08/2003CN1389731A Toxoplasma body, rubella, giant cell, herpes-I and-II virs antigen purifying technique
01/08/2003CN1389730A Clenbterol hydrochloride enzyme immunoassay kit and its immnoassay method
01/08/2003CN1389729A Chloromycetin enzyme immunoassay kit for animal food and its immunoassay method
01/08/2003CN1389728A Dry multipurpose test paper with identification marks
01/08/2003CN1389727A Sea-buckthorn fruit oil identifying method
01/08/2003CN1389722A Spatial multichannel fiber coupler with laser induced synchronous fluorescence detection
01/08/2003CN1389721A Isotope gas spectrometer instrument
01/08/2003CN1389718A Fluff stripping strength test instrument for composite yarn of filament and short staple
01/08/2003CN1098462C Method of determining suppressor cell component of immune status of individual and means for carrying out same
01/08/2003CN1098461C Sensor arrangement
01/08/2003CN1098460C Detection of antibody production
01/08/2003CA2415458A1 Two coloured fluorimetric protease assay
01/07/2003US6505126 Identifying nucleic acids and polypeptides
01/07/2003US6504603 Method and device for detecting undesired matter in eggs
01/07/2003US6504154 Non-destructive sugar content measuring apparatus
01/07/2003US6504022 Human bad polypeptides, encoding nucleic acids and methods of use
01/07/2003US6504009 Transcriptional regulator
01/07/2003US6504007 GDNF receptor
01/07/2003US6503956 Determination of heteroatom content in Fischer-Tropsch wax
01/07/2003US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
01/07/2003US6503761 Selective removal of contaminants from a surface using articles having magnets
01/07/2003US6503760 Method for capturing analytes eluted from surface-bound ligands
01/07/2003US6503759 Encoded combinatorial chemistry is provided, where sequential synthetic schemes are recorded using organic molecules, which define choice of reactant, and stage, as the same or different bit of information. Various products can be produced in the
01/07/2003US6503758 Systems and methods for measuring nitrate levels
01/07/2003US6503753 Method for the development of an HIV vaccine
01/07/2003US6503745 Method of detecting influenza virus, comprising the step of exposing a sample suspected to comprise influenza virus to at least one compound according to claim 1, wherein the at least one compound is capable of binding specifically to the active
01/07/2003US6503742 Ubiquitin ligases and uses related thereto
01/07/2003US6503736 Antibodies to crosslinkers and methods for using the same
01/07/2003US6503724 Noninvasive method for determining the blood coagulation status of an animal, characterized by measuring F1+2, F1, F2, FpA, D-dimers, F1+2 combined with F1, or F1+2 combined with F2 in saliva, where the concentrations of F1+2, F1, F2, FpA,
01/07/2003US6503723 Method for detecting ATP
01/07/2003US6503722 Diagnostic tests and kits for Clostridium difficile
01/07/2003US6503721 High-throughput assay for detection of ligand that binds preferential target sequences; obtain ligands, incubate with nucleotide sequences, monitor conformational adjustments, recover ligand that cause conformational adjustments
01/07/2003US6503720 Method for quantification of an analyte
01/07/2003US6503717 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells
01/07/2003US6503716 Compositions and methods for extracting a nucleic acid
01/07/2003US6503715 Solid support to which one or more specific Nucleic acid ligands is attached in a spatially defined manner. Each Nucleic acid ligand binds specifically and avidly to a particular Target molecule contained within a Test mixture,
01/07/2003US6503713 Methods for identifying RNA binding compounds
01/07/2003US6503711 Nucleic acid biosensor diagnostics
01/07/2003US6503706 The invention addresses DNA-protein-complexes, proteins, DNA sequences and antibodies that are suitable for the detection of cells with an unlimited proliferation and tumor-formation potential. The invention further addresses methods for
01/07/2003US6503703 Identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein.
01/07/2003US6503702 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
01/07/2003US6503701 Analytic sensor apparatus and method
01/07/2003US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections
01/07/2003US6503509 Method for receptor desensitization
01/07/2003US6503454 Multi-ejector system for ejecting biofluids
01/07/2003US6503452 Biosensor arrays and methods
01/07/2003US6503381 Biosensor
01/07/2003US6503198 Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods
01/07/2003US6502573 Portable single patient use carbon dioxide detector
01/07/2003US6502470 Fluid sampling system
01/07/2003US6502456 Method and apparatus for measuring multiple parameters of steam
01/07/2003CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease
01/07/2003CA2100167C Description process of the antibody (ab) repertoires and of the t-cell receptors (tcr) of an individual's immune system
01/07/2003CA2090263C Measuring vessel
01/07/2003CA2064841C Methods and apparatus for quantifying tissue damage
01/06/2003WO2003004559A1 Composite particles, derived conjugates, preparation method thereof and applications of same
01/06/2003CA2445824A1 Composite particles, derived conjugates, preparation method thereof and applications of same
01/05/2003WO2003036285A1 Specific component concentration measuring method and concentration measuring instrument
01/03/2003WO2003001424A1 Measurement assisting device and measurement instrument using the same
01/03/2003WO2003001213A2 Total protein detection methods and devices at low ph
01/03/2003WO2003001212A2 A method for diagnosing a person having multiple sclerosis
01/03/2003WO2003001211A1 Method for testing the presence of prion proteins in tissue and culture samples
01/03/2003WO2003001210A2 Retrovirus associated with myelodysplastic syndromes
01/03/2003WO2003001209A1 Method for monitoring the rate of t-cells recently emigrated from the thymus
01/03/2003WO2003001208A2 Assay and process for the detection of hpv antibodies
01/03/2003WO2003001207A2 Method and device for measuring changes in microviscosity serving as an immune test
01/03/2003WO2003001206A1 Method of mass spectrometry
01/03/2003WO2003001205A1 Method for estimation of the amount of specific cell types
01/03/2003WO2003001204A2 Type 1 diabetes diagnostics and therapeutics
01/03/2003WO2003001203A2 Inverse chromatography methods and apparatus for evaluation of interactions between modifying agents and receptors
01/03/2003WO2003001202A1 Methods and cell populations for identifying and validating genomic targets, and for drug screening
01/03/2003WO2003001201A2 Method for the extra-corporeal qualitative and/or quantitative recording of neuro-toxic substances in the blood plasma of an individual
01/03/2003WO2003001199A2 Determination of in-mouth sensory properties of foodstuffs
01/03/2003WO2003001197A1 Assay for toxin induced neuronal degeneration and viability in c. elegans
01/03/2003WO2003001196A1 Gas chromatograph with flame ionisation detector for parallel hydrocarbon analysis